(Q45392569)

14 December 2017

title

Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis (English)

1 reference

Herpes simplex virus type 1

14 December 2017

0 references

1 reference

4

Guy Boivin

1 reference

14 December 2017

Nicolas Boivin

1

1 reference

14 December 2017

Yan Sergerie

series ordinal

2

1 reference

14 December 2017

Serge Rivest

series ordinal

3

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Journal of Infectious Diseases

14 December 2017

published in

1 reference

14 December 2017

volume

198

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

664-672

1 reference

Herpes simplex encephalitis: children and adolescents

14 December 2017

cites work

1 reference

Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice

21 January 2018

1 reference

Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis

21 January 2018

1 reference

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

21 January 2018

1 reference

Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis

21 January 2018

1 reference

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

Viral and nonviral uses of imiquimod: a review

21 January 2018

1 reference

Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

21 January 2018

1 reference

Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.

21 January 2018

1 reference

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection

21 January 2018

1 reference

Immunostimulatory CpG treatment for genital HSV-2 infections

21 January 2018

1 reference

Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.

21 January 2018

1 reference

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection

21 January 2018

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling

21 January 2018

1 reference

Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.

21 January 2018

1 reference

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

21 January 2018

1 reference

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

21 January 2018

1 reference

Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain

21 January 2018

1 reference

Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment

21 January 2018

1 reference

Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).

21 January 2018

1 reference

Toll-like receptor 9, CpG DNA and innate immunity

21 January 2018

1 reference

The interferon in TLR signaling: more than just antiviral

21 January 2018

1 reference

A universal role for MyD88 in TLR/IL-1R-mediated signaling

21 January 2018

1 reference

IRF3 mediates a TLR3/TLR4-specific antiviral gene program

21 January 2018

1 reference

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

21 January 2018

1 reference

TLR3 deficiency in patients with herpes simplex encephalitis

21 January 2018

1 reference

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

21 January 2018

1 reference

https://api.fatcat.wiki/v0/release/fjkbesxozje3vklvuseck667ci

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_fjkbesxozje3vklvuseck667ci

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fjkbesxozje3vklvuseck667ci

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/fjkbesxozje3vklvuseck667ci

1 reference